Request Demo
Last update 08 May 2025
Ranibizumab biosimilar(Actor Pharmaceuticals)
Last update 08 May 2025
Overview
Basic Info
Drug Type Fab fragment, Biosimilar |
Synonyms Ranibizumab Biosimilar (Actor Pharmaceuticals Pty Ltd), RANIVIZ |
Target |
Action inhibitors |
Mechanism VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Australia (20 Dec 2023), |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 103170L
The sequence is quoted from: *****
Sequence Code 143622H
The sequence is quoted from: *****
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Choroidal Neovascularization | Australia | 20 Dec 2023 | |
| Diabetic macular oedema | Australia | 20 Dec 2023 | |
| Proliferative retinopathy with diabetes mellitus | Australia | 20 Dec 2023 | |
| Retinal vein occlusion-related macular edema | Australia | 20 Dec 2023 | |
| Wet age-related macular degeneration | Australia | 20 Dec 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free